These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19785453)

  • 1. Improving quantitative structure-activity relationships through multiobjective optimization.
    Nicolotti O; Giangreco I; Miscioscia TF; Carotti A
    J Chem Inf Model; 2009 Oct; 49(10):2290-302. PubMed ID: 19785453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors.
    Nicolotti O; Miscioscia TF; Carotti A; Leonetti F; Carotti A
    J Chem Inf Model; 2008 Jun; 48(6):1211-26. PubMed ID: 18540590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M; Morreale A; Ortiz AR
    J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local indices for similarity analysis (LISA)-a 3D-QSAR formalism based on local molecular similarity.
    Verma J; Malde A; Khedkar S; Iyer R; Coutinho E
    J Chem Inf Model; 2009 Dec; 49(12):2695-707. PubMed ID: 19994892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
    Mlinsek G; Novic M; Kotnik M; Solmajer T
    J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding energy analysis for binding affinity and target selectivity prediction.
    Henrich S; Feierberg I; Wang T; Blomberg N; Wade RC
    Proteins; 2010 Jan; 78(1):135-53. PubMed ID: 19768680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
    Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
    J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
    ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
    Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
    J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin.
    Greenidge PA; Mérette SA; Beck R; Dodson G; Goodwin CA; Scully MF; Spencer J; Weiser J; Deadman JJ
    J Med Chem; 2003 Apr; 46(8):1293-305. PubMed ID: 12672230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
    J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
    Santos-Filho OA; Cherkasov A
    J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.